在COPD和AECOPD中准非乳清性免疫路径:当前的见解和治疗策略
Dur E Maknoon Razia1, Chencheng Gao1, Chao Wang1
1College of Basic Medical Sciences, Jilin University, Changchun, 130021, People's Republic of China.
概括
本综述探讨了用于管理慢性阻塞性肺部疾病 (COPD) 的非乙烯酸性免疫路径. 针对这些特定的免疫反应可能会提高治疗效率,并减少传统疗法的副作用.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 涉及空气流量限制和肺炎,导致肺气和慢性支气管炎.
- 目前的治疗方法,如葡萄糖皮质激素和支气管扩展剂提供好处,但携带诸如免疫抑制和感染等风险.
- 需要针对特定免疫和分子组件的新型COPD疗法,以改善结果并最大限度地减少不良影响.
研究的目的:
- 在COPD管理中审查非乙性免疫路径.
- 为了识别除了乙酸性炎症之外的其他免疫学点.
- 探索这些COPD治疗的替代途径的治疗含义.
主要方法:
- 文献综述,重点关注COPD中的非乙性炎症.
- 分析免疫机制及其作为治疗点的潜力.
- 综合发现,突出现有研究和未来方向的差距.
主要成果:
- 现有的文献广泛涵盖了COPD中的eosinophilic炎症.
- 本综述确定并检查了替代的非乙酸性免疫路径.
- 针对特定的免疫反应显示出增强治疗疗效的潜力.
结论:
- 推进对非乙酸性免疫机制的研究对于COPD管理至关重要.
- 针对这些途径的新疗法可以提供比传统治疗更好的疗效和安全性.
- 专注于这些替代途径对于开发更有效的COPD管理策略至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223
Drugs Used in Lower Respiratory Disorders: Overview
333
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
333
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K


